Polianta Ltd purchased a new stake in Cboe Global Markets, Inc. (BATS:CBOE – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 6,000 shares of the company’s stock, valued at approximately $1,506,000.
Other institutional investors have also recently made changes to their positions in the company. Physician Wealth Advisors Inc. boosted its holdings in shares of Cboe Global Markets by 70.5% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 133 shares of the company’s stock valued at $33,000 after buying an additional 55 shares during the last quarter. Twin Peaks Wealth Advisors LLC acquired a new position in Cboe Global Markets during the second quarter worth $33,000. Headlands Technologies LLC bought a new stake in Cboe Global Markets during the second quarter worth $31,000. Ameriflex Group Inc. raised its position in Cboe Global Markets by 97.4% during the third quarter. Ameriflex Group Inc. now owns 154 shares of the company’s stock worth $38,000 after acquiring an additional 76 shares in the last quarter. Finally, Dakota Community Bank & Trust NA acquired a new stake in Cboe Global Markets in the third quarter valued at $42,000. Institutional investors and hedge funds own 81.73% of the company’s stock.
Insiders Place Their Bets
In related news, Director Edward J. Fitzpatrick sold 3,947 shares of Cboe Global Markets stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $285.87, for a total transaction of $1,128,328.89. Following the completion of the sale, the director directly owned 12,921 shares of the company’s stock, valued at approximately $3,693,726.27. This trade represents a 23.40% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Alexander Matturri, Jr. sold 1,500 shares of the business’s stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $285.36, for a total value of $428,040.00. Following the completion of the sale, the director owned 4,761 shares of the company’s stock, valued at $1,358,598.96. This trade represents a 23.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 5,695 shares of company stock worth $1,628,981 over the last three months. Insiders own 0.51% of the company’s stock.
Cboe Global Markets Price Performance
Cboe Global Markets (BATS:CBOE – Get Free Report) last posted its earnings results on Friday, February 6th. The company reported $3.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.93 by $0.13. The company had revenue of $671.10 million during the quarter, compared to analysts’ expectations of $659.59 million. Cboe Global Markets had a net margin of 5.77% and a return on equity of 20.05%. Equities analysts expect that Cboe Global Markets, Inc. will post 6.41 earnings per share for the current year.
Cboe Global Markets Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Friday, February 27th were issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Friday, February 27th. Cboe Global Markets’s dividend payout ratio is currently 98.97%.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on CBOE. Barclays lifted their price objective on shares of Cboe Global Markets from $295.00 to $317.00 and gave the company an “overweight” rating in a research report on Monday, February 9th. TD Cowen reaffirmed a “hold” rating on shares of Cboe Global Markets in a report on Wednesday, January 14th. Argus upgraded shares of Cboe Global Markets to a “hold” rating in a research note on Wednesday, March 11th. UBS Group reiterated a “neutral” rating and set a $290.00 price target on shares of Cboe Global Markets in a report on Monday, February 9th. Finally, Morgan Stanley boosted their price target on Cboe Global Markets from $221.00 to $240.00 and gave the stock an “underweight” rating in a research report on Monday, December 22nd. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Cboe Global Markets currently has an average rating of “Hold” and an average price target of $279.00.
Check Out Our Latest Report on CBOE
Cboe Global Markets Profile
Cboe Global Markets, Inc, through its subsidiaries, operates as an options exchange worldwide. It operates through six segments: Options, North American Equities, Europe and Asia Pacific, Futures, Global FX, and Digital. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities. This segment also offers exchange-traded products (ETP) transaction and listing services. The Europe and Asia Pacific segment provides pan-European listed equities and derivatives transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services.
Featured Stories
Want to see what other hedge funds are holding CBOE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cboe Global Markets, Inc. (BATS:CBOE – Free Report).
Receive News & Ratings for Cboe Global Markets Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cboe Global Markets and related companies with MarketBeat.com's FREE daily email newsletter.
